Drug
Lurasidone 20
Lurasidone 20: highest development phase Phase 3, developed by Sumitomo Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sumitomo Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Lurasidone 20, 40, 60, 80 mg, flexibly dosed NCT01914393 | Phase 3 | Schizophrenia |
Latest
No recent events.
Follow Lurasidone 20 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.